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Abstract. Two potential malaria virulence factors, parasite multiplication rate (PMR) and red blood cell selectivity
(measured as selectivity index [SI]), were assessed in Plasmodium falciparum clinical isolates from Mali and Kenya. At
both sites, PMRs were low (Kenya median  2.2, n  33; Mali median  2.6, n  61) and did not differ significantly
between uncomplicated and severe malaria cases. Malian isolates from hyperparasitemic patients had significantly lower
PMRs (median 1.8, n 19) than other Malian isolates (uncomplicated malaria median 3.1, n 23; severe malaria
median  2.8, n  19; P  0.03, by Kruskal-Wallis test). Selective invasion occurred at both sites (Kenya geometric
mean SI 1.9, n 98; Mali geometric mean SI 1.6, n 104), and there was no significant association between the
SI and malaria severity. Therefore, in contrast to previous results from Thailand, we found no association of PMR and
SI with malaria severity in African children. This raises the possibility of differences in the mechanisms of malaria
virulence between sub-Saharan Africa and Asia.
INTRODUCTION
There is a poor understanding of factors that cause severe
malaria, although host genetics, environmental determinants,
and parasite properties are all thought to play an important
role.1 As far back as the early 20th century when malaria
therapy was used to treat neurosyphilis, differences in Plas-
modium falciparum strain virulence were recognized.2 In
parasite evolutionary theory, differences in strain virulence
can be explained by the trade-off hypothesis, which describes
how parasites evolve to balance the fitness advantages of high
growth and transmission with the fitness cost of host death.3
In other words, parasites that grow faster transmit more ef-
ficiently, but are also more virulent to the host. The relation-
ship between parasite growth rate and virulence has been
shown in rodent malaria models with P. chabaudi.4–6 In hu-
man malaria, P. falciparum virulence was associated with in
vitro parasite multiplication rate (PMR) in a study carried out
in Thailand (severe malaria isolates median PMR  8.3, un-
complicated malaria isolates median PMR  2.8).7 Whether
this relationship between PMR and virulence is seen in other
malaria-endemic countries is unknown.
Further insight into parasite multiplication in vivo can be
gained by understanding whether red blood cell (RBC) inva-
sion is a random, unrestricted process, or whether some se-
lectivity occurs, with only a subset of RBCs being accessible
for invasion. The selectivity index (SI) compares the observed
number of multiple-infected RBCs (containing more than one
ring-stage parasite) to the number expected from a random
Poisson distribution.8 An SI of 1 indicates random, non-
selective invasion of RBCs, whereas an SI of 2 indicates two-
fold more multiple-infected RBCs than expected by chance
alone. Factors that may lead to non-random invasion (SI > 1)
include parasite receptor preference, host RBC polymor-
phisms, or host merozoite-agglutinating antibodies.9–11 An
SI < 1 could occur if invasion by one merozoite rendered an
RBC refractory to further invasion.
Multiple-infected RBCs occur in all human Plasmodium
infections.8 In P. vivax, the SI is high (∼8), which reflects the
preference of P. vivax for reticulocytes and young RBCs.8 In
P. falciparum infections with parasitemias less than 2%, mul-
tiple-infected RBCs are largely the result of the high parasite
load, and the SI is ∼1.8 Plasmodium falciparum infections with
lower parasitemias (< 2%) show a tendency towards higher
RBC selectivity, with a mean SI of 2.44.8 Importantly, after
accounting for parasitemia effects, RBC selectivity of P. fal-
ciparum isolates has been associated with disease severity in
Thailand.8 Severe malaria isolates show random, unrestricted
invasion of RBCs (geometric mean SI  1.35), whereas un-
complicated malaria isolates show restricted, non-random in-
vasion with a higher number of multiple-infected cells (geo-
metric mean SI  2.31).8
Together with the PMR results,7 the above data indicate
that there may be more virulent isolates causing severe ma-
laria in Thai patients due to rapid, unrestricted growth and
subsequent high parasite burdens in the host. The influence of
these factors on malaria severity in African children has not
previously been studied. Therefore, we investigated PMR and
RBC selectivity in relation to malaria virulence in two diverse
sites in Africa.
MATERIALS AND METHODS
Parasite isolates. Parasite isolates were collected in Bandia-
gara, Mali and Kilifi, Kenya. Malaria transmission is seasonal
at both sites, with infective bites ranging from 20 to 60 per
month in Mali12 and 10 to 30 per person per year in Kenya.13
In Mali, there is a single malaria season every year (July–
December), whereas in Kenya there are two malaria seasons
per year (June–August and December–February). The Ma-
lian samples were collected as part of the Bandiagara Malaria
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Project case-control study in which uncomplicated malaria
controls were age, residence, and ethnicity matched to severe
malaria cases.12,14 The World Health Organization (WHO)
criteria for severe malaria were applied,15 although patients
with hyperparasitemia (> 500,000 parasites/L of blood) and
no other symptoms or signs of severe disease were analyzed
as a separate group because previous studies indicated a good
prognosis for these children.14,16 Uncomplicated malaria
cases were all those recruited into the study with fever and P.
falciparum parasitemia who did not have severe malaria or
hyperparasitemia.14,17 In Kenya, children with cerebral ma-
laria (unrousable coma with a Blantyre score  2), prostra-
tion (inability to sit unaided or in babies to breast feed), or
respiratory distress (abnormally deep breathing) were consid-
ered to have severe malaria. The simpler clinical definition
applied in Kenya identifies approximately the same group of
children at risk for life-threatening malaria as those identified
by the more comprehensive WHO criteria.16 In Kenya, un-
complicated cases were children with malaria who came to a
hospital with no symptoms or signs of severe disease and were
treated as outpatients with oral therapy. Blood samples were
collected after obtaining informed consent from the children’s
parents or guardians, and protocols were reviewed and ap-
proved by ethical review boards in the United Kingdom, the
United States, Mali, and Kenya.
After removal of lymphocytes using Lymphoprep (Axis-
Shield UK, Kimbolton, Cambridgeshire, United Kingdom),
Malian isolates were washed and then frozen in glycerolyte by
standard methods and shipped to Edinburgh. The isolates
were thawed using a standard protocol. Briefly the isolates
were diluted in a series of salt solutions (0.2 mL of 12% saline
added slowly, followed by 10 mL of 1.8% saline followed by
10 mL of 0.9% saline/0.2% glucose) and washed in RPMI
1640 medium containing 2 mM glutamine, 37.5 mM HEPES,
20 mM glucose, and 25 g/mL of gentamicin (incomplete
RPMI medium). The cells were resuspended in complete
RPMI medium (incomplete RPMI medium supplemented
with 10% human AB serum), gassed with 3% CO2, 1% O2,
96% N2 and incubated at 37°C. Kenyan isolates were col-
lected into heparinized tubes and put into culture within 12
hours of collection. Lymphocytes and the buffy coat were
removed, the RBC were washed three times in incomplete
RPMI medium, resuspended in complete RPMI medium,
gassed, and incubated as above. Cultures were monitored for
18–48 hours by staining smears with Giemsa, and only those
with normal morphology that matured to the schizont stage
were included in the study. Thai samples were frozen and
shipped to Edinburgh and then thawed and cultured in the
same way as the Malian samples.
Thin blood smears for SI calculations. Thin smears were
prepared from blood collected from the patient on arrival at
hospital and stained with Giemsa. A subset of the slides for SI
calculations are from the isolates used to collect in vitro PMR
data. The remaining slides in both Kenya and Mali were col-
lected from children recruited into other studies of factors
affecting severe malaria.14,18,19
Selectivity index (SI). Three hundred ring-infected RBC
were counted per slide and the number of rings in each RBC
was recorded. The SI was calculated as described in detail by
Simpson and others8 Briefly, the number of observed mul-
tiple-infected RBCs (i.e.,  2 rings per RBC) was divided by
the number of expected multiple-infected RBCs. The latter
was calculated according to a Poisson distribution with pa-
rameter   (-ln(1 - parasitemia). The parasitemia was esti-
mated as the proportion of RBCs infected with at least one
parasite from a count of 1,000 RBCs.
In vitro PMR assay. The assay to determine PMR in the
first cycle of in vitro culture was set up as described by Choti-
vanich and others.7 All parasites were cultured as described
above until the mature schizont stage. The schizonts were
enriched by centrifugation through 60% Percoll. The en-
riched schizonts were washed twice and adjusted to a 1%
parasitemia with normal group A (Malian samples) or group
O (Kenyan samples) RBCs, each from one single healthy
Caucasian donor, respectively. They were incubated in 96-
well plates in a volume of 50 L at a 2% hematocrit with
duplicate wells for each isolate. The 96-well plate was placed
within a gas modulator chamber to allow culturing in 3%
CO2,1% O2, 96% N2 for 24 hours at 37°C. Thin blood films of
the pre-invasion sample and the ring-invaded RBCs after 24
hours were made and stained with Giemsa to determine the
parasitemia. At least 1,000 RBCs from each slide of the du-
plicate wells per sample were counted. The PMR is the num-
ber of ring-infected RBCs after invasion divided by the pre-
invasion parasitemia. The multiplication rate can also be cal-
culated using the total number of ring-stage parasites present
in all infected RBCs after invasion.7 Analysis of the data
using total number of ring-stage parasites rather than the
number of ring-infected RBCs did not materially affect any of
the results shown here; therefore, only data referring to the
number of ring-infected RBCs are given.
Rosette formation. Rosette frequency was assessed by
staining an aliquot of culture suspension with 25 g/mL of
ethidium bromide. A wet preparation of the stained culture
suspension at a 2% hematocrit was viewed with a fluores-
cence microscope, and the percentage of 200 mature-infected
erythrocytes binding 2 uninfected erythrocytes was counted
(the rosette frequency).
Statistical analysis. Statistical analysis was done with Stat-
View 5.0.1 software (SAS Institute, Cary, NC) and Minitab
version 14.1. (Minitab Ltd., Coventry, Warwickshire, United
Kingdom). The power calculation was determined using S-
plus software. Non-parametric tests (Mann-Whitney U or
Kruskal-Wallis) were used for most analyses because of the
non-normality of the data, and correlations were assessed by
Spearman rank correlation. The PMR data were square-root
transformed to conform to normality and homogeneity of
variance assumptions. They were then analyzed using a gen-
eral linear model for the effects of disease severity, parasit-
emia, country of origin, and the interaction between disease
severity and country of origin. Repeating the non-parametric
analysis of the PMR with parametric tests using the trans-
formed data did not materially alter the results. The SI data
were normalized by log transformation. Geometric mean SI
(95% confidence intervals [CIs]) for disease severity groups
were calculated and compared by one-way analysis of vari-
ance (ANOVA). Correlations with SI were assessed by
simple regression.
RESULTS
Clinical and laboratory details of patients in the PMR
study. The laboratory data for the patients in the PMR study
are shown in Table 1. Children with severe malaria tended to
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have higher parasitemias, higher white blood cell counts, and
lower hemoglobin levels than children with uncomplicated
malaria (Table 1). The Kenyan children with severe disease
were younger than those with uncomplicated malaria; how-
ever, this age difference was not seen in the Malian dataset
because age-matching was part of the study design (Table 1).
The parasites from severe malaria cases showed higher ro-
sette frequencies than those from uncomplicated malaria
cases as described previously,18,19 although this was not
statistically significant in Kenya where the sample size
was small (Table 1). Of the 13 Kenyan children with severe
malaria, three had cerebral malaria, five had respiratory dis-
tress and prostration, four had prostration alone, and one had
respiratory distress alone. Of the 19 Malian children with
severe disease, 5 had cerebral malaria (unrousable coma), 10
had other neurologic impairment (prostration, obtundation
or repeated seizures), 2 had respiratory distress, 1 had severe
anemia, and 1 had jaundice. One Malian child with respira-
tory distress died, and all the other children survived.
Lack of an association between field isolate multiplication
rates and disease severity in Kenya and Mali. We measured
the PMR in the first cycle of in vitro culture for 33 Kenyan
and 61 Malian field isolates. A power calculation indicated
that in both Kenya and Mali we had > 99% power to detect
a difference in PMR between severe and uncomplicated iso-
lates as large as that seen in the previous study in Thailand.7
With the sample size and variance shown here for Kenya (the
smallest of the two studies), we had > 90% power at a 5%
error level to detect a difference in the PMR between severe
and uncomplicated isolates as small as 1.8.
The multiplication rates in both Kenya and Mali were low
(Kenya median 2.2, Mali median 2.6, Table 1). In Kenya
there was no significant difference in the PMR of isolates
from severe malaria patients compared with the PMR of iso-
lates from uncomplicated malaria cases (P  0.38 by Mann-
Whitney U test, Figure 1A and Table 1). Similarly, in Mali
there was no significant difference in the PMR of severe ma-
laria isolates compared with uncomplicated malaria isolates
(P 0.27 by Mann-Whitney U test, Figure 1B and Table 1).
Children with uncomplicated malaria had lower parasitemias
than children with severe malaria in both Kenya and Mali
(Table 1), and parasitemia was significantly negatively corre-
lated with PMR in both Kenya and Mali (Kenya:  −0.397,
P  0.025; Mali:   −0.312, P  0.02 Spearman rank cor-
relation; Figure 2). The data on the relationship between
PMR and disease severity were therefore re-analyzed after
adjustment for host parasitemia, and there was still no signifi-
cant difference between the PMR of uncomplicated malaria
isolates compared with severe malaria isolates (F1,29 0.343,
P  0.56 and F1,38  0.120, P  0.73 for Kenya and Mali,
respectively).
The PMR of isolates from cerebral malaria cases in Kenya
(n 3, median 2.7) was not significantly different from the
PMR of isolates from patients with other forms of severe
disease (n  10, median  1.7, P  0.74, by Mann-Whitney
U test). Similarly, in Mali, the PMR of isolates from cerebral
malaria cases (n  5, median  3.5) did not differ signifi-
cantly from the PMR of isolates from other severe malaria
cases (n 14, median 2.5, P 0.17, by Mann-Whitney U
test). The number of isolates in the sub-categories of severe
disease is small, and a larger study would be required to de-
termine conclusively whether there are any significant differ-
ences in PMR among isolates from patients with different
clinical forms of severe malaria.
We also studied patients in Mali with hyperparasitemia
(> 500,000 parasites/L of blood) but no other symptoms or
signs of severe malaria. These patients can be classified as
severe using WHO criteria;15 however, they have a very low
mortality rate and should probably be considered as an inter-
mediate category between severe and mild uncomplicated
TABLE 1
Laboratory data and parasite multiplication rates for patients included in the PMR study in Kenya and Mali*
No.
Age
(months)
Hb
(g/dL)
Parasitemia†
(%)
WBCs
(× 109/L)
Rosette
frequency‡
Parasite
multiplication
rate
Kenya
All patients 33 33 (30) 8.7 (2.6) 6.0 (4.1) 13.7 (12.0) 1.3 (0–5.5) 2.2 (1.1–3.3)
[30] [27] [27] [20]
Uncomplicated 20 44 (35) 9.8 (1.3) 4.0 (2.3) 9.0 (3.6) 1.0 (0–3) 2.3 (1.2–3.6)
[17] [14] [14] [12]
Severe§ 13 20 (11) 7.5 (3.1) 9.1 (4.5) 18.8 (15.6) 3.3 (0–19.3) 1.8 (1.0–2.9)
[8]
P 0.02 0.0125 0.0001 0.003 0.32 0.38
Mali
All patients 61 39 (22) 9.6 (1.8) 8.2 (7.8) 14.0 (7.2) 7.0 (0–17) 2.6 (1.8–3.5)
[60]
Uncomplicated 23 40 (22) 9.6 (1.5) 3.0 (1.7) 13.2 (7.4) 2.0 (0–12) 3.1 (2.3–4.4)
[22]
Severe 19 34 (22) 8.7 (2.4) 7.3 (4.3) 15.7 (8.3) 14.0 (9–24) 2.8 (2.1–3.5)
Hyperparasitemic 19 42 (24) 10.4 (1.1) 15.4 (9.4) 13.1 (5.9) 5.0 (2–20) 1.8 (1.2–2.7)
P 0.54 0.04 < 0.0001 0.48 0.003 0.27¶
0.03#
* Values are the mean (SD) or median (interquartile range). Values in square brackets indicate no. of patients that differ due to missing data. Hb  hemoglobin; WBC  white blood cells.
Rosette frequency and parasite multiplication rates were analyzed by the Mann-Whitney U test (Kenya) or the Kruskal-Wallis test (Mali). Other parameters were analyzed by analysis of variance
or Student’s t-test.
† Percentage of infected red blood cells in 1,000 red blood cells counted.
‡ Percentage of infected red blood cells binding  2 uninfected red blood cells in 200 infected red blood cells counted.
§ Mean (SD) values for additional biochemical tests in severe case are pH 7.34 (0.15), bicarbonate 16.04 mmol/L (5.90), and lactate 5.03 mg/dL (3.56). These tests were not available for
uncomplicated cases in Kenya or any samples from Mali.
¶ Severe versus uncomplicated by Mann-Whitney U test.
# Severe, uncomplicated, and hyperparasitemia groups by Kruskal-Wallis test.
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malaria.14,16 Patients with hyperparasitemia are also found in
Kenya, but were not recruited in the Kenyan study because its
aim was to compare the most severely ill children to those
with mild uncomplicated disease, rather than consider the
intermediate category. Isolates from patients with hyperpara-
sitemia had significantly lower PMRs (median  1.8) than
isolates from other Malian severe and uncomplicated malaria
cases (P 0.03, by Kruskal-Wallis test, Figure 1B and Table
FIGURE 2. Scatter plots indicating the negative correlation between the parasite multiplication rate and host parasitemia of Plasmodium
falciparum isolates from A, Kenya (n  33) and B, Mali (n  61).
FIGURE 1. Parasite multiplication rates (PMRs) of A, Kenyan and B, Malian Plasmodium falciparum isolates from children diagnosed with
uncomplicated or severe malaria. Isolates from Malian children diagnosed with hyperparasitemia (Hyperpt.) are shown as a separate group.
Equivalent children with hyperparasitemia and no other symptoms or signs of severe malaria occur in Kenya, but they were not recruited because
of the study design. The median PMR for each group is indicated by the closed circle and line.
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1). The occurrence of lower PMRs in isolates from patients
with higher parasite burdens was also indicated by the nega-
tive correlation between parasitemia and PMR (Figure 2).
We also examined PMR in relation to three other variables:
patient age as a possible indicator of host immunity, hemo-
globin as an additional measure of disease severity, and para-
site rosette frequency (a known correlate of malaria virulence
in African children).18,19 Age and hemoglobin levels of the
children and the parasite rosette frequency were not corre-
lated with PMR in Mali (P  0.98, P  0.72, and P  0.64,
respectively) or Kenya (P  0.29, P  0.78, and P  0.70,
respectively, by Spearman rank correlation).
The maximum PMR was 6.1 in the Kenyan isolates and 8.9
in the Malian isolates (Figure 1). This is in contrast to the
previous study from Thailand where more than half of the
isolates from severe malaria patients showed between 8- and
25-fold multiplication.7 We used identical methods to those
described in the Thai study; however, our results are so
clearly different to those reported earlier that we decided to
examine the possibility of a technical problem in the PMR
assay. We therefore studied PMR in a small, blinded set of
Thai isolates (kindly provided by Dr. K. Chotivanich and Pro-
fessor N. White, Mahidol University, Bangkok, Thailand).
The PMR assay was set up using blood from the same Cau-
casian donor who was used for the Mali samples. Despite the
small numbers studied, the Thai severe malaria isolates had
higher PMRs (median  7.7, n  4: 1.4, 6.5, 9.0, 10.2) than
the Thai uncomplicated malaria isolates (median  2.2, n
4: 0.4, 2.2, 2.2, 3.5), as shown previously.7 This difference in
PMR between severe and uncomplicated Thai isolates was
significantly greater than that found in the African samples
(country × disease severity interaction: F1,77  5.20, P 
0.008). Thus, technical differences between studies are un-
likely to explain the contrast between P. falciparum isolates
from Thailand and Africa in the relationship between PMR
and severe malaria.
Clinical and laboratory details of patients in the SI
study. The laboratory data for the children in the SI study are
shown in Table 2. The severe malaria patients had lower he-
moglobin levels, higher parasitemias, and higher white blood
cell counts than the children with uncomplicated malaria. The
parasite isolates from the severe malaria patients had signifi-
cantly higher rosette frequencies than the parasite isolates
from the uncomplicated malaria and hyperparasitemic pa-
tients (Table 2). Of the 46 Kenyan children with severe ma-
laria, 20 had cerebral malaria, 11 had respiratory distress
and prostration, 11 had prostration alone, 2 had respiratory
distress alone, and 2 were missing the clinical details on the
sub-category of severe disease. Of the 46 Malian children
with severe malaria, 13 had cerebral malaria, 23 had other
neurologic impairment (prostration, obtundation, or repeated
seizures), 2 had respiratory distress, 5 had severe anemia, and
3 had jaundice. Six Malian and 3 Kenyan children with severe
disease died, and there were no deaths among children with
uncomplicated malaria or those who were hyperparasitemic.
Negative correlation of SI of field isolates with para-
sitemia. We examined thin blood smears from 98 Kenyan and
104 Malian children. The geometric mean SI was 1.92 (95%
CI  1.65–2.19) for Kenyan isolates and 1.61 (95% CI 
1.12–2.10) for Malian isolates, which indicated non-random,
selective invasion at both sites. The SI in both Kenya and Mali
was negatively correlated with host parasitamia (Kenya r 
−0.523, Mali r -0.526, P < 0.001 in both cases, Figure 3). To
allow direct comparison with previous data,8 we grouped the
SI into four categories (< 2% parasitemia, 2.1–5%, 5.1–10%,
and > 10%–maximum, Figure 4). The < 2% parasitemia
group had a significantly higher SI than the other parasitemia
groups in both Kenya and Mali (P < 0.02, by Student’s t-test,
with all clinical categories within each parasitemia group com-
bined).
Simple regression showed that the SI was not correlated
with age (P 0.63 and P 0.76), hemoglobin (P 0.49 and
TABLE 2
Laboratory data and selectivity index for patients included in the selectivity index analysis in Kenya and Mali*
No.
Age
(months)
Hb
(g/dL)
Parasitemia†
(%)
WBC
(× 109/L)
Rosette
frequency‡
Selectivity index
(geometric mean
(95% CI))
Kenya
All patients 98 33 (26) 8.1 (2.5) 6.5 (6.1) 13.2 (13.1) 4.25 (1–13.5) 1.92 (1.65–2.19)
[79] [74] [45] [62]
Uncomplicated 52 40 (27) 9.4 (1.5) 4.2 (2.9) 9.0 (3.9) 1.5 (0–7) 2.05 (1.55–2.55)
[37] [32] [21] [31]
Severe§ 46 27 (23) 7.0 (2.6) 9.0 (7.7) 16.9 (16.9) 6.5 (2.5–17.5) 1.79 (1.58–2.01)
[42] [42] [24] [31]
P 0.022 < 0.0001 < 0.0001 0.044 0.009 0.56
Mali
All patients 104 39 (24) 9.0 (2.4) 7.6 (7.0) 13.9 (7.7) 12 (2–22) 1.61 (1.12–2.10)
[101] [98]
Uncomplicated 33 38 (20) 9.4 (1.7) 3.3 (2.5) 12.9 (6.3) 2 (0–14.5) 1.86 (0.60–3.11)
[32]
Severe 46 38 (25) 8.2 (2.9) 6.9 (5.7) 15.4 (9.3) 18.5 (11.5–37) 1.55 (0.86–2.25)
[45] [40]
Hyperparasitemic 25 44 (25) 10.2 (1.5) 14.8 (8.0) 12.3 (5.5) 5 (2–19.5) 1.44 (1.21–1.67)
[24]
P 0.58 0.003 < 0.0001 0.19 < 0.0001 0.62
* Values are the mean (SD) or median (interquartile range) unless otherwise indicated. Values in square brackets indicate no. of patients that differ due to missing data. Hb  hemoglobin;
WBC white blood cells; CI confidence interval. Rosette frequency was analyzed by the Mann-Whitney U test (Kenya) or the Kruskal-Wallis test (Mali). Other parameters were analyzed
by analysis of variance or Student’s t-test.
† Percentage of infected red blood cells in 1,000 red blood cells counted.
‡ Percentage of infected red blood cells binding  2 uninfected red blood cells in 200 infected red blood cells counted.
§ Mean (SD) values for additional biochemical tests in severe case are pH 7.26 (0.15), n  23, bicarbonate 13.97 mmol/L (5.85), n  23, and lactate 6.91 mg/dL (4.35), n  23. These tests
were not available for uncomplicated cases in Kenya or any samples from Mali.
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P  0.68) or parasite rosette frequency (P  0.95 and P 
0.24 for Kenya and Mali, respectively). The latter result was
of particular interest because we had hypothesized that ro-
sette formation might increase the SI if it resulted in prefer-
ential invasion into the RBCs forming the rosettes. The lack
of correlation between rosette formation and SI suggests that
invasion is not targeted into the uninfected erythrocytes in
rosettes, a finding that agrees with previous work.20
Lack of an association between SI and disease severity. We
examined whether the SI differed among isolates from chil-
dren with uncomplicated or severe malaria or hyperpara-
sitemia (Figure 4 and Table 2). One-way analysis of variance
FIGURE 4. Geometric mean selectivity index (SI) of Plasmodium falciparum isolates from A, Kenya and B, Mali separated by patient malaria
severity (black bars uncomplicated; white bars severe, gray bars hyperparasitemia) and host parasitaemia group. Errors bars show 95%
confidence intervals. Four samples with an SI of 0 (i.e., no multiple-infected cells) were excluded (two Kenyan and two Malian). maxmaximum.
FIGURE 3. Scatter plots indicating the negative correlation between the selectivity index and host parasitemia of Plasmodium falciparum
isolates from A, Kenya (n  98) and B, Mali (n  104).
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with parasitemia grouping included as a covariate showed no
significant difference in the SI of isolates from the different
disease severity groups (F1,93  0.14, P  0.71 and F1,73 
0.255, P 0.62 for Kenya and Mali, respectively). There was
also no significant difference between uncomplicated and se-
vere cases if only parasitemias less than 5% were analyzed in
accordance with previous data from Thailand.8 With our
sample sizes and variance we had > 97% power to detect a
difference between severe and uncomplicated isolates equiva-
lent to that measured in Thailand.8
The SI of isolates from children in Kenya with cerebral
malaria (geometric mean  1.72, 95% CI  1.29–2.15, n 
20) did not differ significantly from the SI of isolates from
children with other forms of severe disease (geometric
mean 1.85, 95% CI 1.59–2.11, n 26, F1,44 0.53, P
0.47, by ANOVA). Similarly, in Mali, the SI of isolates from
children with cerebral malaria (geometric mean 1.23, 95%
CI  0.88–1.58, n  13) did not differ significantly from the
SI of isolates from children with other forms of severe disease
(Mali geometric mean  1.70, 95% CI  0.74–2.67, n  33,
P  0.18, F1,43  1.894, P  0.18, by ANOVA).
Multiplication rate in relation to SI. We also examined the
relationship between SI and PMR. There was a negative cor-
relation between SI and PMR in Kenya (n 29,  −0.410,
P  0.03, by Spearman rank correlation, Figure 5A). How-
ever, in Mali there was no significant correlation between the
SI and PMR (n 60,  0.015, P 0.91, by Spearman rank
correlation, Figure 5B). It might be expected that isolates
with high selectivity would have a low PMR, resulting in a
negative correlation between SI and PMR as seen in Kenya
(Figure 5A). It is unclear why this relationship was not seen in
the Malian isolates (Figure 5B).
DISCUSSION
In this study, we assessed two indicators of P. falciparum
invasiveness (PMR and SI) and determined the relationship
of these factors to malaria severity. The PMR measures para-
site multiplication under standard conditions in the first cycle
of in vitro culture, whereas the SI is determined from blood
smears taken directly from patients. There was no significant
difference in the PMR and SI of isolates from severe malaria
patients compared with isolates from uncomplicated malaria
patients in two diverse sites in Africa. This lack of association
with severe malaria is in contrast to previous studies on PMR
and SI from Thailand.7,8 We were able to exclude technical
differences as the source of this discrepancy in results because
a small, blinded study of Thai isolates in our laboratory con-
firmed the previously published data.7 The PMR of the Af-
rican isolates were mostly in the range of 1–6 fold (Figure 1),
and are comparable to those of uncomplicated malaria iso-
lates from Thailand.7 However, isolates with high PMR in the
10–22-fold range characteristic of severe malaria cases in
Thailand were absent from Africa. It seems extraordinary
that many isolates in both Africa and Thailand should have
such low PMR when every schizont produces approximately
24 merozoites. We only used healthy parasites that matured
well for one cycle in culture for the PMR assays; however, we
do not know how well the in vitro assay reflects PMR in vivo.
The high PMR seen in Thai severe malaria isolates are in
agreement with estimates of PMR in vivo from recent studies
with the P. falciparum laboratory-adapted clone 3D7 infect-
ing European volunteers21–23 and from retrospective analysis
of data collected during neurosyphilis treatment pro-
grams.24,25 To our knowledge, there are no comparable data
FIGURE 5. Scatter plots indicating the relationship between the parasite multiplication rate (PMR) and selectivity index (SI) of Plasmodium
falciparum isolates from A, Kenya (n  29) and B, Mali (n  60). These samples are the subset from the SI data shown in Figure 3 for which
there is corresponding PMR data.
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available for in vivo PMR using fresh clinical isolates, or from
any parasite clones in semi-immune individuals.
Why should there be a difference between Asia and Africa
in the association of PMR and SI with parasite virulence? In
Thailand (and most of southeast Asia), malaria transmission
levels tend to be low, there is little acquired immunity in the
population, and severe malaria affects all age groups.26 In
contrast, in sub-Saharan Africa, malaria transmission tends to
be moderate to high, older children and adults show partial
immunity to malaria, and severe disease mainly occurs in chil-
dren less than five years of age. It is possible that the different
levels of immunity to malaria in the two regions are respon-
sible for the diverse results highlighted here. Partial immunity
in African patients could delay the course of infection and
lead them to present at hospitals later than Asian patients, by
which time differences between isolates in PMR and SI may
no longer be apparent. If such a scenario were true, one might
expect African children experiencing their first malaria infec-
tions after maternally acquired immunity has waned to show
higher PMR more typical of those seen in Thailand. However,
there was no correlation between age and PMR in our study,
and isolates from children between 6 and 12 months of age
who are unlikely to have had many previous malaria infec-
tions did not have higher PMR than isolates from older chil-
dren (Kenya: infants, n  5, median PMR  1.5; older chil-
dren, n  25, median PMR  2.3, P  0.52, by Mann-
Whitney U test; Mali: infants, n  4, median PMR  2.7;
older children, n  57, median PMR  2.6, P  0.79, by
Mann-Whitney U test). There was also no significant corre-
lation between age and SI, and isolates from children in the
6–12-month age group did not show significantly higher SI
than isolates from older children (Kenya: infants, n  13,
geometric mean SI  1.77, 95% CI  1.38–2.16; older chil-
dren, n  66, geometric mean SI  1.86, 95% CI  1.55–
2.17, F1,75  0.15, P  0.70, by ANOVA; Mali: infants, n 
8, geometric mean SI  1.70, 95% CI  0.06–3.34; older
children, n  96, geometric mean SI  1.60, 95% CI 
1.08–2.12, F1,100  0.05, P  0.82, by ANOVA). The small
number of children in the 6–12-month age group at both sites
reflects the relative rarity of severe malaria in children less
than one year of age in these areas. A prospective study with
active surveillance would be required to determine conclu-
sively whether parasites from African children experiencing
their first malaria infection show higher PMR and lower SI
than parasites from older children.
An alternative explanation of our results is that parasites
adapted to grow in semi-immune populations in sub-Saharan
Africa have evolved different mechanisms of virulence com-
pared with those adapted to grow in non-immune populations
in Asia. The growth of parasites within the host during the
asexual blood stage depends upon the multiplication potential
of the parasite and ability of the host to remove infected
RBCs. It is plausible that in Asia, in the absence of significant
levels of immunity, virulent parasites reach high parasite bur-
dens within the host by having high PMRs. In Africa, para-
sites with high PMRs may not be effective in reaching high
parasite burdens because of the presence of invasion-blocking
antibodies in many hosts. In this case, parasite properties con-
tributing to avoidance of the host’s immune system clearance
mechanisms may be more important in helping a parasite to
achieve high parasite burdens, produce high levels of sexual
stages, and maximize its transmission and fitness.
Could the relationship between PMR and in vivo parasit-
emia explain the differences between African and Thai iso-
lates? The interaction between parasitemia and PMR was not
commented upon in the Thai study, and the parasitemias of
the patients were not shown. However, high parasite burdens
equivalent to those seen in Africa are not uncommon in
southeast Asia; therefore, we believe it is unlikely that differ-
ences in parasitemia levels explain the diverse results from
the two areas. In the current study we have carried out addi-
tional analysis on the subset of samples with parasitemias less
than 5%, and on all data after adjustment to take into account
host parasitemia effects. In both cases, there was no signifi-
cant association between disease severity and PMR and SI in
African children.
Whatever the explanation for the discrepancies between
sub-Saharan Africa and Asia indicated by this study, our re-
sults raise the possibility that different pathogenic mecha-
nisms of severe malaria may operate in parts of the world with
different malaria transmission levels. This possibility is sup-
ported by studies of another potential virulence factor, ro-
sette formation, which is associated with severe disease in
multiple sites in Africa,19,27,28 but not in Asia.29,30 The hy-
pothesis that Asian and African parasites differ in virulence
properties could be tested in the absence of confounding ef-
fects of host immunity and host genetics by studying isolates
infecting non-immune travelers.
One striking finding from our study was that isolates from
Malian patients with hyperparasitemia had significantly lower
multiplication rates than other Malian isolates (Figure 1 and
Table 1). Additionally, there was a negative correlation be-
tween in vivo parasitemia and PMR across all isolates from
both Kenya and Mali (Figure 2). These results seem counter-
intuitive because one might expect that isolates reaching high
parasitemias in vivo would have the highest multiplication
rates rather than the lowest. Density-dependent mechanisms
are thought to occur in vivo to prevent excessive expansion of
parasite populations, and can be determined by the availabil-
ity of host RBCs, the presence of host immunity, or down-
regulation of parasite invasiveness.31–34 Our data are consis-
tent with P. falciparum having the ability to down-regulate its
multiplication rate to avoid overwhelming the host. We are
not aware of any other experimental evidence to support such
an idea; however, it is plausible that switching of invasion
pathways35–39 could potentially underlie such a process. It
would be of great interest to examine the relationship be-
tween particular invasion pathways and parasite PMR and SI,
and to determine whether the PMR and SI are stable prop-
erties of each isolate or can vary in response to external
stimuli. An initial study found no association between inva-
sion pathways and SI in Gambian field isolates.40 An alter-
native interpretation of the finding that isolates from hyper-
parasitemic patients have very low PMRs is that slowly mul-
tiplying parasites may do less damage to their hosts and
therefore are able to reach high parasitemias without causing
the type of life-threatening disease manifestations seen in the
severe malaria group.
One similarity between Thai and African isolates is that
RBC selectivity is highest at low parasitemias, with isolates
from patients with parasitemias less than 2% having signifi-
cantly higher SI than other groups (Figures 3 and 4). Parasites
with restricted invasion (high SIs) may be unable to reach
high parasitemias. A parallel to this occurs in P. yoelii, where
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virulent strains that invade normocytes reach higher parasit-
emias than avirulent strains that have a strong reticulocyte
preference.41,42 An alternative explanation for the high SI at
low parasitemia is that the presence of host antibodies to
merozoites could lead to partial blocking of invasion and keep
the parasitemia low, while also agglutinating merozoites and
increasing the number of multiple invasions.9
In this study we have found no evidence to support a role
for high parasite multiplication or lack of RBC selectivity as
virulence factors in African children, a finding that contrasts
sharply with previous work from southeast Asia.7,8 Other
virulence factors such as rosette formation19,27,28 and platelet-
mediated clumping43 may play a major role in parasite viru-
lence in sub-Saharan Africa, whereas PMR and RBC selec-
tivity are more important in Asia. If distinct pathogenic
mechanisms underlie severe malaria in different parts of the
world, this could have implications for the development of
new strategies to treat and prevent severe disease. The dif-
ferences in pathogenic mechanisms of severe malaria in re-
gions of varying malaria transmission in both Africa and Asia
are therefore worthy of further study.
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